Kinnate Biopharma Inc. financial data

Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2023 - 28 Mar 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47,225,312 shares 1.4%